熱門資訊> 正文
Sea、DraftKings、Sasol等上市前输家
2024-05-28 20:48
- Marpai (MRAI) -41% on notice of delisting or failure to satisfy a continued listing rule.
- OneMedNet (ONMD) -20%.
- Gold Royalty (GROY) -15% after agreeing to acquire a copper stream on the Vares silver project, operated by Adriatic Metals PLC and located in Bosnia and Herzegovina, from Orion Mine Finance Management, launches $30M bought deal financing.
- Lichen China (LICN) -13%.
- Paranovus Entertainment Technology (PAVS) -13%.
- TransCode Therapeutics (RNAZ) -12%.
- Akanda (AKAN) -11%.
- Raytech Holding (RAY) -10%.
- Minim (MINM) -10%.
- DraftKings (DKNG) -7% on rumors to be looking at a full acquisition of Simplebet.
- Altamira Therapeutics (CYTO) -7%.
- BriaCell Therapeutics (BCTX) -6% after announces study to evaluate the effects of Bria-OTS™ in combination with anti-PD-1 antibody tislelizumab, in advanced, late stage, heavily pretreated metastatic breast cancer.
- Solowin (SWIN) -5% after announces strategic partnership with MaiCapital Limited.
- Sea (SE) -5% after Shopee face Indonesia probe over alleged favoring of own delivery service - report.
- Atlantica Sustainable Infrastructure (AY) -5% after it agreed to be acquired by Energy Capital Partners for $22/share in cash.
- Sasol (SSL) -5%.
- See the biggest morning stock movers.
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
